VBIO
Price:
$0.28
Market Cap:
$896.27K
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Industry
Biotechnology
IPO Date
2021-11-11
Stock Exchange
NASDAQ
Ticker
VBIO
According to Valion Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -18.83%. This represents a change of -121.53% compared to the average of 87.46% of the last 4 quarters.
The mean historical ROE of Valion Bio, Inc. over the last ten years is 375.11%. The current -18.83% ROE has changed -105.02% with respect to the historical average. Over the past ten years (40 quarters), VBIO's ROE was at its highest in in the December 2012 quarter at 466.77%. The ROE was at its lowest in in the June 2012 quarter at -116240.37%.
Average
375.11%
Median
-37.37%
Minimum
-1394.18%
Maximum
3.76%
Discovering the peaks and valleys of Valion Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.62%
Maximum Annual ROE = 3.76%
Minimum Annual Increase = -5211.57%
Minimum Annual ROE = -1394.18%
| Year | ROE | Change |
|---|---|---|
| 2021 | -102.02% | -70.03% |
| 2020 | -340.41% | -15.12% |
| 2019 | -401.04% | -70.01% |
| 2018 | -1337.06% | -4.10% |
| 2017 | -1394.18% | -5211.57% |
| 2016 | 27.28% | -92.73% |
| 2015 | 375.09% | -90.02% |
| 2014 | 3.76% | 679.56% |
| 2013 | 482.30% | -82.01% |
| 2012 | 2.68% | 5.62% |
The current ROE of Valion Bio, Inc. (VBIO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-281.16%
5-year avg
-714.94%
10-year avg
375.11%
Valion Bio, Inc.’s ROE is less than Organicell Regenerative Medicine, Inc. (455.87%), greater than OptiBiotix Health Plc (-52.92%), less than Kadimastem Ltd (0.08%), greater than OKYO Pharma Limited (-200.67%), greater than Vinergy Capital Inc. (-78.83%), greater than Sorrento Therapeutics, Inc. (-1904.94%), less than American Hemp Ventures, Inc. (0%), less than Antisense Therapeutics Limited (0%), greater than TPCO Holding Corp. (-91.05%), greater than Biofrontera AG (-476.72%),
| Company | ROE | Market cap |
|---|---|---|
| 455.87% | $19.97M | |
| -52.92% | $20.06M | |
| 0.08% | $9.50M | |
| -200.67% | $22.73M | |
| -78.83% | $20.57M | |
| -1904.94% | $16.54M | |
| 0% | $16.47M | |
| 0% | $19.64M | |
| -91.05% | $20.12M | |
| -476.72% | $19.35M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valion Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Valion Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Valion Bio, Inc.'s ROE?
How is the ROE calculated for Valion Bio, Inc. (VBIO)?
What is the highest ROE for Valion Bio, Inc. (VBIO)?
What is the 3-year average ROE for Valion Bio, Inc. (VBIO)?
What is the 5-year average ROE for Valion Bio, Inc. (VBIO)?
How does the current ROE for Valion Bio, Inc. (VBIO) compare to its historical average?